Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B

Mary K O'Reilly1, Brian E Collins, Shoufa Han

  • 1Department of Chemical Physiology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, California 92037, USA.

Insights

Researchers developed a synthetic molecule to target CD22 (a B cell regulator) using antibody scaffolds. This method efficiently assembles complexes on B cells, showing potential for targeting B cell malignancies.

Area of Science:

  • Immunology
  • Biochemistry
  • Cell Biology

Background:

  • CD22 is a B cell-specific lectin regulating B cell signaling.
  • Its function is modulated by specific sialic acid-containing glycan ligands (NeuAc α2-6Gal).
  • Previously, only highly multivalent ligands (n=450) could bind CD22 on native B cells.

Purpose of the Study:

  • To develop a synthetic molecule for efficient CD22 complex assembly on B cells.
  • To investigate the role of antibody valency and ligand structure in CD22 binding.
  • To explore the potential for targeted B cell therapy.

Main Methods:

  • Synthesized bifunctional molecules linking CD22 ligands to nitrophenol (NP) antigens.
  • Utilized monoclonal anti-NP IgM (decavalent), IgA (tetravalent), and IgG (divalent) as protein scaffolds.
  • Analyzed complex formation on native B cells using varying linker lengths and structures.

Main Results:

  • A synthetic CD22 ligand linked to NP efficiently drove IgM-CD22 complex assembly on B cells.
  • Lower valency antibodies (IgA, IgG) also induced complex formation, albeit with reduced avidity.
  • Ligand structure and linker length influenced complex assembly, with a minimal length requirement identified.
  • Complex assembly was exclusive to CD22-expressing B cells, not other leukocytes.

Conclusions:

  • Bifunctional molecules can leverage antibody scaffolds for targeted CD22 engagement on B cells.
  • This approach offers a versatile strategy for modulating B cell surface interactions.
  • The B cell-specific targeting capability holds promise for treating B cell malignancies.

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...